BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29502024)

  • 1. Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy.
    Nocentini A; Moi D; Balboni G; Salvadori S; Onnis V; Supuran CT
    Bioorg Chem; 2018 Apr; 77():633-639. PubMed ID: 29502024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors.
    Nocentini A; Moi D; Balboni G; Onnis V; Supuran CT
    Bioorg Chem; 2018 Apr; 77():293-299. PubMed ID: 29421705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation.
    Moi D; Nocentini A; Deplano A; Balboni G; Supuran CT; Onnis V
    Eur J Med Chem; 2019 Nov; 182():111638. PubMed ID: 31472471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
    Kumar R; Vats L; Bua S; Supuran CT; Sharma PK
    Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase I, II, IV and IX inhibition with a series of 7-amino-3,4-dihydroquinolin-2(1H)-one derivatives.
    Bozdag M; Bua S; Osman SM; AlOthman Z; Supuran CT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):885-892. PubMed ID: 28644059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity.
    Kumar R; Sharma V; Bua S; Supuran CT; Sharma PK
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1187-1194. PubMed ID: 28891338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation and computational studies of novel iminothiazolidinone benzenesulfonamides as potent carbonic anhydrase II and IX inhibitors.
    Mahmood SU; Saeed A; Bua S; Nocentini A; Gratteri P; Supuran CT
    Bioorg Chem; 2018 Apr; 77():381-386. PubMed ID: 29421714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates.
    Winum JY; Pastorekova S; Jakubickova L; Montero JL; Scozzafava A; Pastorek J; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2005 Feb; 15(3):579-84. PubMed ID: 15664816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action.
    Havránková E; Csöllei J; Vullo D; Garaj V; Pazdera P; Supuran CT
    Bioorg Chem; 2018 Apr; 77():25-37. PubMed ID: 29324250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
    Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors.
    Vats L; Kumar R; Bua S; Nocentini A; Gratteri P; Supuran CT; Sharma PK
    Eur J Med Chem; 2019 Dec; 183():111698. PubMed ID: 31539777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
    Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
    Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.
    Akocak S; Lolak N; Nocentini A; Karakoc G; Tufan A; Supuran CT
    Bioorg Med Chem; 2017 Jun; 25(12):3093-3097. PubMed ID: 28400084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel 4-functionalized 1,5-diaryl-1,2,3-triazoles containing benzenesulfonamide moiety as carbonic anhydrase I, II, IV and IX inhibitors.
    Vats L; Sharma V; Angeli A; Kumar R; Supuran CT; Sharma PK
    Eur J Med Chem; 2018 Apr; 150():678-686. PubMed ID: 29571155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides.
    Mete E; Comez B; Inci Gul H; Gulcin I; Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(sup2):1-5. PubMed ID: 27435177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis-sulfamate adducts with isozymes II and IX as a platform for designing tight-binding, more isoform-selective inhibitors.
    Vitale RM; Alterio V; Innocenti A; Winum JY; Monti SM; De Simone G; Supuran CT
    J Med Chem; 2009 Oct; 52(19):5990-8. PubMed ID: 19731956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase inhibitors: aliphatic N-phosphorylated sulfamates--a novel zinc-anchoring group leading to nanomolar inhibitors.
    Bonnac L; Innocenti A; Winum JY; Casini A; Montero JL; Scozzafava A; Barragan V; Supuran CT
    J Enzyme Inhib Med Chem; 2004 Jun; 19(3):275-8. PubMed ID: 15500000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors.
    Angeli A; Carta F; Bartolucci G; Supuran CT
    Bioorg Med Chem; 2017 Jul; 25(13):3567-3573. PubMed ID: 28522267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors.
    Yamali C; Gul HI; Ece A; Bua S; Angeli A; Sakagami H; Sahin E; Supuran CT
    Bioorg Chem; 2019 Nov; 92():103222. PubMed ID: 31499260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.